MATK
Megakaryocyte-associated tyrosine-protein kinase
Also known as: CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MATK_HUMAN, MGC1708, MGC2101
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42679
- Gene
- MATK
- Ensembl
- ENSG00000007264
- Chromosome
- 19
- Canonical length
- 507 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol
OverviewNCBI Gene
The protein encoded by this gene has amino acid sequence similarity to Csk tyrosine kinase and has the structural features of the CSK subfamily: SRC homology SH2 and SH3 domains, a catalytic domain, a unique N terminus, lack of myristylation signals, lack of a negative regulatory phosphorylation site, and lack of an autophosphorylation site. This protein is thought to play a significant role in the signal transduction of hematopoietic cells. It is able to phosphorylate and inactivate Src family kinases, and may play an inhibitory role in the control of T-cell proliferation. This protein might be involved in signaling in some cases of breast cancer. Three alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>P42679|MATK
1 MAGRGSLVSW RAFHGCDSAE ELPRVSPRFL RAWHPPPVSA RMPTRRWAPG TQCITKCEHT
61 RPKPGELAFR KGDVVTILEA CENKSWYRVK HHTSGQEGLL AAGALREREA LSADPKLSLM
121 PWFHGKISGQ EAVQQLQPPE DGLFLVRESA RHPGDYVLCV SFGRDVIHYR VLHRDGHLTI
181 DEAVFFCNLM DMVEHYSKDK GAICTKLVRP KRKHGTKSAE EELARAGWLL NLQHLTLGAQ
241 IGEGEFGAVL QGEYLGQKVA VKNIKCDVTA QAFLDETAVM TKMQHENLVR LLGVILHQGL
301 YIVMEHVSKG NLVNFLRTRG RALVNTAQLL QFSLHVAEGM EYLESKKLVH RDLAARNILV
361 SEDLVAKVSD FGLAKAERKG LDSSRLPVKW TAPEALKHGK FTSKSDVWSF GVLLWEVFSY
421 GRAPYPKMSL KEVSEAVEKG YRMEPPEGCP GPVHVLMSSC WEAEPARRPP FRKLAEKLAR
481 ELRSAGAPAS VSGQDADGST SPRSQEPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MATK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 56 nTPM
- hippocampal formation: 54 nTPM
- amygdala: 45 nTPM
- basal ganglia: 36 nTPM
- hypothalamus: 20 nTPM
- bone marrow: 19 nTPM
Single-cell type
- tuft cells: 496 nCPM
- nk-cells: 180 nCPM
- t-cells: 67 nCPM
- megakaryocyte-erythroid progenitors: 45 nCPM
- megakaryocyte progenitors: 43 nCPM
- innate lymphoid cells: 38 nCPM
Immune cell
- NK-cell: 77 nTPM
- gdT-cell: 46 nTPM
- MAIT T-cell: 31 nTPM
- memory CD8 T-cell: 29 nTPM
- naive CD8 T-cell: 17 nTPM
- total PBMC: 7.6 nTPM
Brain region
- cerebral cortex: 91 nTPM
- hippocampal formation: 58 nTPM
- white matter: 52 nTPM
- basal ganglia: 42 nTPM
- amygdala: 41 nTPM
- hypothalamus: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.81
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- SH2 domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- CSK-like, SH2 domain
- SH3-like domain superfamily
- SH2 domain superfamily
- Non-receptor tyrosine kinases involved in cell signaling
- SH2 domain
- SH3 domain
- Protein tyrosine and serine/threonine kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MATK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MATK as an antibody target. Whether an autoantibody or antibody against MATK could matter depends on whether native MATK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MATK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MATK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...